David Moradi, Director, 10% Owner at KALOBIOS PHARMACEUTICALS INC (KBIO), bought 3,410 shares at $29.32 ($100K) on 2015-12-16, disclosed to the SEC on 2015-12-18.
Open-market purchase of $100k KBIO by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| AEYE | BUY | 2023-09-18 | $335K | — | Filing → |
| AEYE | BUY | 2023-03-20 | $25K | — | Filing → |
| AEYE | BUY | 2023-03-17 | $34K | — | Filing → |